RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted eight newly-hired employees restricted stock units (RSUs) covering an aggregate of 57,000 shares of BioCryst common stock. The RSUs were granted as of July 1, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
BENGALURU, India, July 3, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that...
Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.
Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.
SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately...
CHICAGO and PUNE, India, July 2, 2025 /PRNewswire/ --
What's Behind the Surge in the US$3.22 Billion Feed Phosphate Market?
The Feed Phosphate Market is projected to be...
Double the impact: IKEA Richmond will match back to school essentials donated by customers.
RICHMOND, BC, July 2, 2025 /CNW/ - IKEA Richmond is teaming...
Fuel your pickleball game with Eggland's Best for your chance to win big
CEDAR KNOLLS, N.J., July 2, 2025 /PRNewswire/ -- The rally continues! There's still...
Invivyd Forms SPEAR (Spike Protein Elimination and Recovery) Study Group with Researches to Assess Effects of Monoclonal Antibody Therapy for Long COVID
The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....